Novo Nordisk CEO defends high price off Ozempic and Wegovy

IE 11 is not supported. For an optimal experience visit our site on another browser.

  • Now Playing

    Novo Nordisk CEO defends high price off Ozempic and Wegovy

    04:50

  • UP NEXT

    Growing threat of mosquito-borne diseases

    01:40

  • Growing threat of mosquito-borne diseases

    01:40

  • Some patients now turn to copycat versions of popular weight loss drugs

    03:30

  • How to care for your hair health as fall approaches

    04:34

  • Health officials warn of rise in two viruses spread by mosquitoes

    02:21

  • NBC News Exclusive: Ozempic and Wegovy Novo Nordisk CEO speaks out on high prices, drug shortages

    04:20

  • Dangerous mosquito-borne diseases threaten communities

    01:20

  • Health roundup: New COVID boosters, mpox, more

    04:30

  • Strategies to live a longer and healthier life

    05:24

  • Growing health emergency over new, more deadly strain of Mpox

    01:25

  • Man bleeding from hair transplant surgery removed from flight

    02:26

  • People with HIV cannot be barred from joining the military, judge rules

    00:38

  • FDA expected to approve new COVID booster: What to know

    02:26

  • New effort to protect workers who struggle in stifling heat

    02:15

  • Texas UPS driver passes out, crashes in extreme heat

    02:13

  • Alan Cumming narrates Edgar Allan Poe sleep story for Calm app

    00:58

  • ‘Boy Meets World’ star Danielle Fishel reveals cancer diagnosis

    02:11

  • Try these functional exercises to make everyday activities easier

    04:48

  • How to save on prescription medications and avoid scams

    05:38

NBC News’ Meagan Fitzgerald sits down with Novo Nordisk CEO Lars Jorgenson in Denmark to discuss the high costs and limited supply of the company’s popular weight loss drugs, Ozempic and Wegovy.

Source link